Tumour marker
A substance, usually a protein, that a tumour releases into the blood in measurable amounts. Rising or falling levels track whether the cancer is growing or responding, though they are rarely good enough for diagnosis on their own.
Classic tumour markers are PSA (prostate), CA-125 (ovarian), CEA (colorectal), CA 19-9 (pancreatic), AFP (liver, germ cell), beta-hCG (germ cell) and LDH (a general marker of tumour bulk); most are also made by normal tissue or raised by benign conditions, so they lack the specificity to diagnose cancer and mostly serve to monitor known disease. PSA screening is the well-known exception and the standing example of the trade-off between finding cancers early and overdiagnosing harmless ones. Circulating tumour DNA is in effect a new generation of tumour marker, more specific because it carries the tumour's own mutations.
Pages like this
not linked directly; found by shared links- IdeaBreak the neutrophil DNA nets that catch tumour cells after surgery
Shares Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA), Pancreatic ductal adenocarcinoma, Colorectal cancer.
- IdeaAutomatic germline testing for every cancer type where it changes care
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer, Colorectal cancer.
- InstitutionPrince of Wales Hospital / Chinese University of Hong Kong
Shares Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA), Hepatocellular carcinoma, Colorectal cancer.
- TargetEpCAM
Shares Liquid biopsy (ctDNA), Ovarian cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer.
- InstitutionAustralasian Gastro-Intestinal Trials Group
Shares Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA), Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma.
- IdeaSMART designs to test treatment strategies, not just single drugs
Shares Circulating tumour DNA (ctDNA), Prostate cancer, Colorectal cancer.
- IdeaA test to tell true oligometastatic disease from hidden widespread spread
Shares Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA), Prostate cancer, Colorectal cancer.
- InstitutionINCLIVA Biomedical Research Institute / Hospital Clínico Universitario de Valencia
Shares Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA), Pancreatic ductal adenocarcinoma, Colorectal cancer.